Page last updated: 2024-09-03

tyrosyl-glycyl-glycine and Opportunistic Infections

tyrosyl-glycyl-glycine has been researched along with Opportunistic Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cone, LA; Fiala, M; Sayre, JW1

Trials

1 trial(s) available for tyrosyl-glycyl-glycine and Opportunistic Infections

ArticleYear
Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo.
    International journal of immunopharmacology, 1991, Volume: 13, Issue:7

    Topics: Adult; AIDS-Related Complex; Double-Blind Method; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphokines; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Sarcoma, Kaposi

1991